Post by Oncode Accelerator

𝘽𝙪𝙞𝙡𝙙𝙞𝙣𝙜 𝘽𝙧𝙞𝙙𝙜𝙚𝙨: 𝗧𝗮𝗿𝗴𝗲𝘁 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗣𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴 & 𝗔𝘂𝘁𝗼𝗧𝗦𝗔 𝗳𝗼𝗿 𝗦𝗺𝗮𝗹𝗹 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗲 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 Join the next Oncode Accelerator webinar, which brings together two complementary approaches to de-risking early-stage drug development in oncology, with a focus on 𝘀𝗺𝗮𝗹𝗹 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲𝘀!  🗓️ 6 October 2026 ⏰ 16:00 - 17:00 CET 📍 Teams Jennifer McCormack-Venhorst, Senior Scientist Integrator at TNO, will open with a presentation on 𝘼𝙪𝙩𝙤𝙏𝙎𝘼: 𝙁𝙖𝙨𝙩𝙚𝙧 𝙏𝙖𝙧𝙜𝙚𝙩 𝙎𝙖𝙛𝙚𝙩𝙮 𝘿𝙚𝙘𝙞𝙨𝙞𝙤𝙣𝙨 𝙛𝙤𝙧 𝘿𝙧𝙪𝙜 𝘿𝙞𝙨𝙘𝙤𝙫𝙚𝙧𝙮, sharing TNO's AI-driven approach to automating target safety assessments. 💡 She will make the case for why these assessments belong early in drug development pipelines, especially for smaller biotechs that often skip this step until it's too late. Anthe Janssen, Co-founder and CSO of Omivera and Assistant Professor at Universiteit Leiden, follows with 𝙏𝙖𝙧𝙜𝙚𝙩 𝙀𝙣𝙜𝙖𝙜𝙚𝙢𝙚𝙣𝙩 𝙋𝙧𝙤𝙛𝙞𝙡𝙞𝙣𝙜 𝘼𝙘𝙧𝙤𝙨𝙨 𝘾𝙤𝙢𝙥𝙡𝙚𝙭 𝘽𝙞𝙤𝙡𝙤𝙜𝙞𝙘𝙖𝙡 𝙎𝙮𝙨𝙩𝙚𝙢𝙨 𝙐𝙨𝙞𝙣𝙜 𝘾𝙝𝙚𝙢𝙞𝙘𝙖𝙡 𝙋𝙧𝙤𝙩𝙚𝙤𝙢𝙞𝙘𝙨. 💡He will address why selectivity profiling needs to move beyond biochemical assays into living-cell systems that better capture the complexity drug developers actually face.  For more information and registration 👉 https://lnkd.in/eZFeSar8